Canton Strategic Holdings (CNTN) Change in Cash (2021 - 2026)
Canton Strategic Holdings posted quarterly Change in Cash of $24.5 million for Q1 2026, up 1086.51% year-on-year from $2.1 million in Q1 2025, and up 160.01% on a QoQ basis from $9.4 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 6 years of Change in Cash data on file, last reported at $24.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 1086.51% year-over-year to $24.5 million; the trailing twelve-month figure through Mar 2026 stood at $40.5 million (up 650.32% YoY), and the FY2025 full-year result was $13.5 million, up 282.67% from the prior year.
- Change in Cash for Q1 2026 stood at $24.5 million, up from $9.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $24.5 million in Q1 2026 and bottomed at -$3.1 million in Q3 2024.
- The 5-year median for Change in Cash is -$1.1 million (2022), against an average of $2.4 million.
- Peak annual rise in Change in Cash reached 6665.0% in 2022, while the deepest fall reached 24311.56% in 2022.
- A 5-year view of Change in Cash shows it stood at -$1.1 million in 2022, then jumped by 859.23% to $8.2 million in 2023, then plunged by 114.73% to -$1.2 million in 2024, then soared by 875.59% to $9.4 million in 2025, then jumped by 160.01% to $24.5 million in 2026.
- The last three Change in Cash figures came in at $24.5 million (Q1 2026), $9.4 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 24.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.50 Mn |
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -531,463.00 |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | 334,825.00 |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -1.09 Mn |
| Sep 30, 2022 | -1.89 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | 11.12 Mn |
| Dec 31, 2021 | -40,739.00 |
| Sep 30, 2021 | 15,824.00 |
| Jun 30, 2021 | 6,764.00 |
| Mar 31, 2021 | -169,345.00 |